Treatment for mild-intermittent asthma is:
A) Daily inhaled medium-dose corticosteroids
B) Short-acting beta 2 agonists (albuterol) as needed
C) Long-acting beta 2 agonists every morning as a preventative measure
D) Montelukast (Singulair) daily
Correct Answer:
Verified
Q4: The first-line therapy for mild-persistent asthma is:
A)High-dose
Q5: Asthma exacerbations at home are managed by
Q6: Medications used in the management of chronic
Q7: One goal of asthma management in children
Q8: Patients with a COPD exacerbation may require:
A)Doubling
Q10: Patients with COPD require monitoring of:
A)Beta 2
Q11: Patients who are at risk of a
Q12: Monitoring a patient with persistent asthma includes:
A)Monitoring
Q13: One goal of asthma therapy outlined by
Q14: In children age 5 to 11 years
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents